Search for: "Ortho-McNeil Pharmaceutical"
Results 181 - 200
of 270
Sort by Relevance
|
Sort by Date
20 Oct 2009, 8:27 am
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 On October 19, 2009, the Department of Justice announced that four pharmaceutical manufacturers, Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals, and Ortho McNeil Pharmaceutical… [read post]
20 Oct 2009, 1:15 am
The US Attorney’s office in New Hampshire announced yesterday the settlement of a qui tam alleging that four pharmaceutical companies - Mylan Pharmaceuticals, UDL Laboratories, Aztra-Zeneca Pharmaceuticals, and Ortho-McNeill - mischaracterized their prescription drugs to state Medicaid programs. [read post]
6 Oct 2009, 10:44 am
Between November 1997 and December 2005, the FDA received 262 reported cases of tendon ruptures, 258 cases of tendonitis, and 274 cases of other tendon disorders associated with the drug sold by Ortho-McNeil Pharmaceutical, Inc. [read post]
29 Sep 2009, 7:21 am
” The Ortho Evra birth control patch is still available for sale to this day. [read post]
29 Sep 2009, 7:21 am
” The Ortho Evra birth control patch is still available for sale to this day. [read post]
22 Sep 2009, 5:32 am
William Dowling filed a lawsuit Thursday against J&J and its units Ortho McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
4 Sep 2009, 12:11 pm
Noting Ortho-McNeil Pharm., Inc. v. [read post]
3 Sep 2009, 1:13 am
Defendants Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development are denying that Levaquin is defective or unreasonably dangerous. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
27 Aug 2009, 7:43 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
26 Aug 2009, 9:59 pm
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which relates to a tramadol and acetaminophen composition for use in prescription pain relief. [read post]
26 Aug 2009, 5:14 pm
Ortho-McNeil Pharmaceutical v. [read post]
26 Aug 2009, 9:20 am
ORTHO-MCNEIL PHARMACEUTICAL v. [read post]
22 Aug 2009, 11:03 pm
MANUFACTURER: Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
19 Aug 2009, 5:41 am
(Patent Docs) US: BIO files amicus brief in Bilski (Patent Docs) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) US: European biosimilars market may hint at limited US threat (GenericsWeb) US: Chris Hansen on the Myriad lawsuit (Patents4Life) Products Effexor (Venlafaxine) – US: Wyeth files suit alleging Alphapharm’s Enlafax infringes its Venlafaxine patent; Generic Health, which recently registered… [read post]
10 Aug 2009, 10:06 pm
Plaintiffs for Levaquin lawsuits claim the manufacturer, Ortho-McNeil-Janssen Pharmaceuticals, failed to research its product adequately prior to bringing Levaquin to market in 1996 and failed to warn about adverse effects to the tendon. [read post]
6 Aug 2009, 11:24 pm
" Ortho-McNeil Pharm., Inc. v. [read post]
24 Jul 2009, 1:31 am
Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil Janssen's oral contraceptive, Ortho Tri-Cyclen ® Lo. [read post]
